Oncology

We have access to state-of-the-art laboratories and are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of prostate cancer.

Research areas

  • Gene targeting
  • Therapies
  • Biomarkers
  • Clinical trials

Targeted Cancer Therapy Research Group

The Targeted Cancer Therapy Group in the Section of Oncology is headed by Professor Hardev Pandha and is based at the Leggett building. The group has access to state of the art laboratories and are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of prostate cancer. 

Visit the Targeted Cancer Therapy Research Group website

Meet the team

Team lead

Mohammad Asim profile image

Dr Mohammad Asim

Senior Lecturer (Associate Professor) in Cancer Biology & Therapeutics

Team members

Tony Dhillon profile image

Dr Tony Dhillon

Senior Lecturer in Oncology, University of Surrey, Consultant Medical Oncologist, Royal Surrey County Hospital

Adam Frampton profile image

Dr Adam Frampton

Head of Oncology; Assoc. Professor in Surgical Oncology; Consultant General & Hepato-Pancreato-Biliary (HPB) Surgeon

Agnieszka Michael profile image

Dr Agnieszka Michael

Professor in Oncology , Consultant Medical Oncologist, Medical Director of Surrey CTU

Hardev Pandha profile image

Professor Hardev Pandha

Professor of Medical Oncology

Kate Relph profile image

Dr Kate Relph

Project manager